Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

7.1%

1 terminated out of 14 trials

Success Rate

91.7%

+5.1% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

45%

5 of 11 completed with results

Key Signals

5 with results92% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (14)

Trial Status

Completed11
Terminated1
Active Not Recruiting1
Enrolling By Invitation1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (14)

Showing 14 of 14 trials
Showing all 14 trials

Research Network

Activity Timeline